tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRSP Stock Latest News

Crispr Therapeutics price target lowered to $74 from $82 at Chardan
The FlyCrispr Therapeutics price target lowered to $74 from $82 at Chardan
2d ago
CRSP
Cathie Wood Doubles Down on This AI Stock, Cuts GitLab (GTLB) Again
PremiumMarket News
Cathie Wood Doubles Down on This AI Stock, Cuts GitLab (GTLB) Again
3d ago
BLSH
CRCL
Crispr Therapeutics AG Faces Stock Price Slide
PremiumWeekend Updates
Crispr Therapeutics AG Faces Stock Price Slide
6d ago
CRSP
Cathie Wood Buys Nvidia, ACHR and Crypto Stocks, Offloads AMD, EXAS
PremiumMarket News
Cathie Wood Buys Nvidia, ACHR and Crypto Stocks, Offloads AMD, EXAS
7d ago
AMD
ACHR
Citizens JMP healthcare analysts hold an analyst/industry conference
PremiumThe Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
10d ago
BNTC
CRSP
Crispr Therapeutics rumor highlighted in Betaville blog
PremiumThe FlyCrispr Therapeutics rumor highlighted in Betaville blog
11d ago
CRSP
Crispr Therapeutics call volume above normal and directionally bullish
Premium
The Fly
Crispr Therapeutics call volume above normal and directionally bullish
14d ago
CRSP
Cathie Wood Sells Tesla (TSLA) and SoFi Stocks, Makes a $34M Bet on This USDC Giant
Premium
Market News
Cathie Wood Sells Tesla (TSLA) and SoFi Stocks, Makes a $34M Bet on This USDC Giant
15d ago
TEM
CRCL
Crispr Therapeutics price target lowered to $77 from $87 at Citi
PremiumThe Fly
Crispr Therapeutics price target lowered to $77 from $87 at Citi
16d ago
CRSP
Promising Outlook for Crispr Therapeutics AG: Buy Rating Backed by Strong Product Launches and Strategic Developments
PremiumRatings
Promising Outlook for Crispr Therapeutics AG: Buy Rating Backed by Strong Product Launches and Strategic Developments
16d ago
CRSP
CRISPR Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
CRISPR Therapeutics Reports Q3 2025 Financial Results
16d ago
CRSP
FDA appoints Richard Pazdur as Director of CDER
PremiumThe Fly
FDA appoints Richard Pazdur as Director of CDER
17d ago
AZN
BMY
Crispr Therapeutics price target raised to $50 from $42 at RBC Capital
PremiumThe FlyCrispr Therapeutics price target raised to $50 from $42 at RBC Capital
17d ago
CRSP
Crispr Therapeutics price target lowered to $44 from $52 at Baird
Premium
The Fly
Crispr Therapeutics price target lowered to $44 from $52 at Baird
17d ago
CRSP
Crispr Therapeutics price target lowered to $69 from $70 at JPMorgan
Premium
The Fly
Crispr Therapeutics price target lowered to $69 from $70 at JPMorgan
17d ago
CRSP
Crispr Therapeutics AG: Hold Rating Amid Financial Challenges and Mixed Pipeline Progress
PremiumRatings
Crispr Therapeutics AG: Hold Rating Amid Financial Challenges and Mixed Pipeline Progress
18d ago
CRSP
Crispr Therapeutics price target lowered to $50 from $52 at Clear Street
PremiumThe Fly
Crispr Therapeutics price target lowered to $50 from $52 at Clear Street
18d ago
CRSP
Crispr Therapeutics reports Q3 EPS ($1.17), consensus ($1.29)
PremiumThe Fly
Crispr Therapeutics reports Q3 EPS ($1.17), consensus ($1.29)
18d ago
CRSP
Promising Prospects for Crispr Therapeutics AG: CTX310’s Breakthrough in Cardiovascular Care
PremiumRatings
Promising Prospects for Crispr Therapeutics AG: CTX310’s Breakthrough in Cardiovascular Care
18d ago
CRSP
3 Best Stocks to Buy Now, 11/10/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 11/10/2025, According to Top Analysts
18d ago
AVPT
CRSP
Promising Phase I Results of CTX310 Justify Buy Rating for CRISPR Therapeutics
Premium
Ratings
Promising Phase I Results of CTX310 Justify Buy Rating for CRISPR Therapeutics
18d ago
CRSP
Promising Efficacy of Crispr Therapeutics’ CTX310 in Dyslipidemia Treatment Drives Buy Rating
Premium
Ratings
Promising Efficacy of Crispr Therapeutics’ CTX310 in Dyslipidemia Treatment Drives Buy Rating
18d ago
CRSP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >